MEDSOURCE TECHNOLOGIES HOLDINGS, LLC

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Post-effective amendment to a registration statement

Registration statement under Securities Act of 1933 (amendment)

Notice of Effectiveness

Prospectus Supplement for Primary Offering

Correspondence with the SEC

Post-effective amendment to a registration statement

Registration statement under Securities Act of 1933 (amendment)

Letter from the SEC

Registration statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Registration (IPO) statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Registration statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Registration statement under Securities Act of 1933 (amendment)

Registration statement under Securities Act of 1933 (amendment)

Registration statement under Securities Act of 1933 (amendment)

Registration statement under Securities Act of 1933

Correspondence with the SEC

Correspondence with the SEC

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

No description available

General form for quarterly reports under Section 13 or 15(d)

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

No description available

Other events

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

General form for quarterly reports under Section 13 or 15(d)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

12,7

General form for quarterly reports under Section 13 or 15(d)

12,7

Definitive Proxy Statement

Annual report pursuant to Section 13 or 15(d)

5,7

Financial statements and exhibits

General form for quarterly reports under Section 13 or 15(d)

9

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Definitive Proxy Statement

Annual report pursuant to Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

06,UL

Schauer Dean

Schauer Dean

DAHL ROLF

POLUMBO RALPH M

SNIDER ROBERT R

UTI CORP

POLUMBO RALPH M

POLUMBO RALPH M

SNIDER ROBERT R

CROTEAU DANIEL C

KULLBACK WILLIAM J

DAHL ROLF

EFFRESS RICHARD J